Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacokinetics of Asparaginase and Antibody Formation in Interfant-06

This study has been completed.
Information provided by (Responsible Party):
Birgitte Klug Albertsen, Aarhus University Hospital Identifier:
First received: December 2, 2009
Last updated: March 3, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)